Evidence map›Paper›PMID 37602920›Full record

ArticleInternational journal of cancer2023

Stage 4N neuroblastoma before and during the era of anti-G

Brian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, Ellen M Basu, Justin T Gerstle, Kim Kramer, Stephen S Roberts, Suzanne L Wolden, Nai-Kong V Cheung, Shakeel Modak

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Brian H KushnerDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Michael P LaQuagliaDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Fiorella Iglesias CardenasDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ellen M BasuDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Justin T GerstleDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kim KramerDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Stephen S RobertsDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Suzanne L WoldenDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Nai-Kong V CheungDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Shakeel ModakDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0002-7280-1726
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NIH HHS P30 CA008748
6 · The paper itself

Abstract

Patients with stage 4N neuroblastoma (distant metastases limited to lymph nodes) stand out as virtually the only survivors of high-risk neuroblastoma (HR-NB) before myeloablative therapy (MAT) and immunotherapy with anti-G

Indexed as

Neoplasm Recurrence, LocalNeuroblastomaAdolescentChildHumansImmunotherapyInfantNeoplasm StagingN-Myc Proto-Oncogene ProteinPrognosisN-Myc Proto-Oncogene Proteinimmunotherapymetastasesneuroblastomaprognosisradiotherapy

Identifiers

PMID37602920
PMCPMC11925214
OpenAlexW4386020325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.